Nephrostomy Devices Market - By Product (Guidewires, Drainage Tubes, Nephrostomy Catheters, Sheath Dilators), By End-use (Hospitals, Clinics, Ambulatory Surgical Centers) & Global Forecast, 2023 – 2032

Nephrostomy Devices Market Size

Nephrostomy Devices Market size was valued at around USD 1.1 billion in 2022 and is anticipated to grow at a CAGR of over 8.3% between 2023 and 2032.This incremental growth rate is owing to increasing prevalence of kidney disorders coupled with rising demand for minimally invasive surgeries.
 

Technological advancements pertaining to nephrostomy devices in the diagnosis and treatment of several chronic ailments including bladder, ovarian, and prostate cancers is expected to augment the market growth in the forecasted timeframe. Rising healthcare spending for providing better healthcare infrastructure, increasing disposable income and consistently increasing geriatric population are some of the major factors responsible for increased adoption of nephrostomy devices across the world.
 

A nephrostomy device is a medical device used to drain urine from the kidney through a tube that is inserted through the skin and into the kidney. These devices are intended to remove an obstruction in the urinary tract, such as a kidney stone or tumor, that is preventing urine from flowing properly.
 

However, availability of substitute procedures for nephrostomy can act as a significant barriers and thereby impede the nephrostomy devices market growth in the coming years. There are several alternative procedures that may be used instead of a nephrostomy, depending on the specific medical condition and individual circumstances of the patient. This procedure is majorly used to treat kidney stones, tumors, or other obstructions in the urinary tract.
 

COVID-19 Impact

When COVID-19 swept the globe early in 2020, it hit the industry that makes devices for kidneys hard. The virus spread like wildfire, hurting businesses in many sectors, including healthcare. This setback made it tough for the market for nephrostomy devices to grow. Travel restrictions meant that hospitals and clinics saw fewer patients with urinary problems and performed fewer nephrostomy procedures. But later in the year, the situation started to improve. The number of COVID-19 cases went down, and healthcare facilities slowly started getting back to doing the same number of procedures as before the pandemic.

Nephrostomy Devices Market Trends

Hey there! You've probably heard that kidney problems are becoming more common, right? Well, that means more people will need nephrostomy devices to help them out. Why the sudden rise in kidney trouble? It's a mix of thingshow we eat, how we live, how many of us are getting older, and even how fat we are. All these factors are like fuel for the market for nephrostomy devices. Kidney problems like kidney stones, tumors, and infections can block the tubes that carry urine out of the body. That's where nephrostomy devices come in. They're like little drains that help drain urine from the kidney. Let me give you an exampleA study by the U.S. Department of Health and Human Services and National Cancer Institute found that there were about 82,290 new cases of bladder cancer in the U.S. in 2023. That's a lot of people who might need nephrostomy devices! So, with all these people having kidney problems, it's no wonder that nephrostomy devices are becoming more and more popular.

Nephrostomy Devices Market Analysis

The market for nephrostomy devices is divided into different product categories like guidewires, drainage tubes, and catheters. Among these, guidewires were the big players in 2022, taking up over 32% of the market. Why are guidewires so popular? Well, they're not just there to show off. They play a crucial role in helping doctors place devices safely and accurately in kidneys. By guiding the way, they reduce the chances of bleeding and other complications that could harm nearby organs. Plus, guidewires make the whole procedure a lot smoother and less painful for patients. They help minimize tissue damage and discomfort, which can make a big difference in their recovery.

Imagine a bustling hospital, where patients come seeking help with kidney troubles. Nephrostomy devices are like lifelines for these patients, providing relief and healing. Hospitals play a crucial role in this life-saving work, and that's why they hold the lion's share of the nephrostomy device market. Over the next decade, hospitals are set to grow even bigger in this sector, with a projected growth of 8.2% each year. Why? Because they offer the latest treatments for kidney problems, including high-tech urinary catheters that help countless patients. And with more and more people suffering from kidney disorders due to our fast-paced lives, the need for these devices in hospitals is only going to grow. So, as hospitals continue to invest in advanced treatments and provide a wider range of services, the use of nephrostomy devices is bound to skyrocket. With better care and diagnosis available, more and more patients will turn to hospitals for help, driving the market even higher.

U.S. nephrostomy devices market is predicted to reach around USD 863 million by 2032. This market share is attributable to numerous variables including the presence of key market players, an increase in the number of chronic diseases, and rising awareness regarding the benefits of pre nephrostomy devices for diagnosis and treatment of kidney ailments among others.
 

Nephrostomy Devices Market Share

Some of the major players operating in the nephrostomy devices market are

• Angiodynamics
•  Argon Medical Devices Inc
•  B. Braun Melsungen AG
•  Becton
•  Dickinson and Company
•  Boston Scientific Corporation
•  Cardinal Health
•  Coloplast Group 
• Cook Medical
•  Envaste Ltd
•  Meditech
•  Devices Pvt Ltd
•  Olympus Corporation
•  ROCAMED
•  Teleflex Inc. and Uresil LLC.,

These leading market players are implementing advanced technologies to cater to the large unmet needs of the consumers. These players focus on strategic partnerships, new product launch & commercialization for market expansion. Furthermore, these players are heavily investing in research that allows them to introduce innovative products.
 

Nephrostomy Devices Industry in News

• In August 2020, Argon Medical Devices, Inc. announced the launch of SKATER Mini-Loop Drainage Catheters for nephrostomy procedures in the U.S. and Europe. This device uses a 40% smaller loop to help secure the catheter and drain fluid from smaller cavities. This innovative product launch helped the company to increase their product portfolio and enhance their business revenue.
   
• In 2019, Argon Medical Devices, Inc., announced the acquisition of Mana-Tech, Ltd.  a distributor of medical devices including nephrostomy devices in the UK and Ireland. This acquisition helped the company to enhance their customer base and provide growth opportunity to expand our commercial reach throughout Europe.
   

Nephrostomy devices market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million & Units from 2018 to 2032, for the following segments

Click here to Buy Section of this Report

By Product

• Guidewires
• Drainage Tubes
• Nephrostomy Catheters
• Sheath Dilators
• Others

By End-use

• Hospitals
• Clinics
• Ambulatory Surgical Centers
• Others  

The above information is provided for the following regions and countries

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Poland
  • Sweden
  • The Netherlands
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Indonesia
  • Thailand
  • Philippines
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Chile
  • Peru
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Egypt
  • Turkey